GI
AMRI

GAMCO Investors’s Albany Molecular Research Inc AMRI Stock Holding History

GAMCO Investors’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-162,073
Closed -$3.52M – 865
2017
Q2 		$3.52M Buy
+162,073
New +$2.94M 0.02% 417

Other funds holding AMRI

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

GAMCO Investors's AMRI Position: Q3 2017 in Review

GAMCO Investors sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 162,073 shares — an estimated $3.52M sold.

GAMCO Investors first reported a position in AMRI in Q2 2017 and held it in 1 quarter. The position peaked at $3.52M in Q2 2017. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

  • GAMCO Investors reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
  • GAMCO Investors sold 162,073 Albany Molecular Research Inc shares in Q3 2017, an estimated $3.52M.
  • GAMCO Investors first reported a position in Albany Molecular Research Inc in Q2 2017 and held it in 1 quarter.
  • GAMCO Investors's Albany Molecular Research Inc position peaked at $3.52M in Q2 2017.
  • 2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on GAMCO Investors's 13F filing for Q3 2017, filed 1 Nov 2017.